Xanodyne

About:

Xanodyne Pharmaceuticals is an integrated specialty pharmaceutical company focused on women’s healthcare and pain management.

Website: http://www.xanodyne.com

Top Investors: Apax Partners, Longitude Capital, MPM Capital, Silver Point Capital, L.P., Aisling Capital

Description:

Xanodyne Pharmaceuticals, Inc. operates as an integrated specialty pharmaceutical company that offers developing and commercializing products in women’s healthcare and pain management in the United States.The company was formerly known as Xanodyne Pharmacal, Inc. and changed the name to Xanodyne Pharmaceuticals, Inc. in February, 2004. Xanodyne Pharmaceuticals, Inc. was incorporated in 2000 and is based in Newport, Kentucky.

Total Funding Amount:

$308M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Newport, Kentucky, United States

Founded Date:

2000-01-01

Founders:

Gilbert Gonzales, Roger Griggs

Number of Employees:

51-100

Last Funding Date:

2009-10-30

IPO Status:

Private

© 2025 bioDAO.ai